Prescription behavior for gastroprotective drugs in new users as a result of communications regarding clopidogrel – proton pump inhibitor interaction

Safety concerns of the concomitant use of clopidogrel and proton pump inhibitors (PPIs) were published in 2009 and 2010 by the medicines regulatory agencies, including a direct healthcare professional communication. We examined the association between various safety statements and prescription behav...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruik‐Kollöffel, Willemien J., van der Palen, Job, Kruik, H. Joost, van Herk‐Sukel, Myrthe P. P., Movig, Kris L. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242171/
https://www.ncbi.nlm.nih.gov/pubmed/28116095
http://dx.doi.org/10.1002/prp2.242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242171/
https://www.ncbi.nlm.nih.gov/pubmed/28116095
http://dx.doi.org/10.1002/prp2.242

Ejemplares similares